Skip to main content
Equibles

NORTHERN TRUST CORP

Bank

Position in ANIX — Anixa Biosciences Inc

CIK 73124 CHICAGO, IL
Back to ANIX Full portfolio

Position in ANIX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$193,858
+$21,450 QoQ
Shares Held
69,235
+3.6% QoQ
Ownership
0.203%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 62 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. ANIX ranks #319 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,486,478 $1,235,108,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 916,467 $571,453,829
3 ALNY
Alnylam Pharmaceuticals, Inc.
 886,900 $266,983,504
4 RPRX
Royalty Pharma plc
 4,718,859 $264,586,419
5 RVMD
Revolution Medicines, Inc.
 1,117,110 $209,212,357
6 MRNA
Moderna, Inc.
 2,985,329 $209,062,587
7 INCY
Incyte Corp
 1,761,966 $199,736,460
8 CYTK
Cytokinetics Inc
 1,647,345 $140,337,319

All Filings in ANIX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $193,858 69,235
2026-03-31 $172,408 66,825
2025-12-31 $173,996 55,768
2025-09-30 $187,968 56,960
2025-06-30 $220,050 66,682
2025-03-31 $190,710 66,682
2024-12-31 $154,702 66,682
2024-09-30 $223,776 71,040
2024-06-30 $156,998 71,040
2024-03-31 $195,505 62,662
2023-12-31 $199,808 51,497
2023-09-30 $174,761 53,444
2023-06-30 $172,358 53,862
2023-03-31 $251,433 58,473
2022-12-31 $248,688 58,515
2022-09-30 $287,893 58,515
2022-06-30 $174,169 56,918
2022-03-31 $155,954 56,918
2021-12-31 $178,879 60,229
2021-09-30 $292,314 61,282
2021-06-30 $237,773 61,282
2021-03-31 $229,726 49,087
2020-12-31 $151,322 49,291
2020-09-30 $126,388 52,012
2020-06-30 $139,906 45,721
2020-03-31 $85,417 53,722